Industrial COVID-19 Aggravates Nonindustrial Conditions

This file does not affect the Copyright Notice that actually appears on the site.

To update that Notice, submit a request to Bartsoz, who created the Wiki.

INDUSTRIAL COVID-19 AGGRAVATES NONINDUSTRIAL CONDITIONS

As discussed in the prior chapter, an employer would be liable for disability or death if an employee's nonindustrial COVID-19 was aggravated or accelerated by an industrial work injury. The opposite is also true. An employer would be liable if an employee contracts COVID-19 on an industrial basis, and the disease aggravates or accelerates a nonindustrial condition.

For example, if an employee with non-industrial hypertension, chronic lung disease, heart disease, or other condition dies as a result of COVID-19 which was contracted at work, then the employee's death would be compensable. The employer would be required to treat any non-industrial conditions if the treatment was necessary to treat the industrially-related COVID-19. Furthermore, if an employee's industrially-related COVID-19 permanently aggravated a nonindustrial condition, the employer would be fully liable for the treatment without apportionment.

However, the majority of people who contract COVID-19 only experience minor symptoms and fully recover. If the industrial injury or condition causes only a temporary exacerbation of a nonindustrial condition, and the employee fully recovers from the effects of the industrial, the employer is not liable for ongoing care of the nonindustrial condition.

For example, in Reff v. Workers' Comp. Appeals Bd., the appeals board held that a nurse who contracted occupational pneumonia was not entitled to lifetime medical treatment for her pre-existing and dormant common variable immune deficiency (CVID) when it was only temporarily lit up by the occupational disease. The board explained that "if it is established that the medical treatment or medication in question is required separate and apart, or independent of, an industrial injury or condition, then the employer may avoid liability." The board found the medical evidence established the industrial pneumonia temporary aggravated or lit up the non-industrial CVID condition for about two months. Consequently, it concluded there was no legal basis for a permanent award of medical treatment for the CVID condition.

Therefore, if an employee contracts COVID-19 on an industrial basis and it temporarily exacerbates a non-industrial condition, the employer would be required to provide treatment during the temporary exacerbation. However, if the employee fully recovers from COVID-19 without any permanent aggravation of the non-industrial condition, the employer's liability for treatment of the non-industrial condition ceases. Ultimately, whether the COVID-19 temporarily exacerbates or permanently aggravates a non-industrial condition will be a medical issue.